SG

Shakaribahen Govindbhai Patel

Active Director Director DIN 11731592
DIN 11731592 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Shakaribahen Govindbhai Patel

Data last updated:

Shakaribahen Govindbhai Patel is a Director at Ocim Pharma Private Limited (since 2026).

DIN 11731592
Primary Designation Director
First Appointment 20 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ocim Pharma Private Limited U49231GJ2026PTC178235
Director20 May 20262026Active

Board colleagues of Shakaribahen Govindbhai Patel

NameDINCompanyDesignation
Govindbhai Maganlal Patel11731591Ocim Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ocim Pharma Private Limited
Premium access

Shareholding and investment profile for Shakaribahen Govindbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shakaribahen Govindbhai Patel

Shakaribahen Govindbhai Patel currently holds 1 directorship: Ocim Pharma Private Limited (Director, since 20 May 2026).

Shakaribahen Govindbhai Patel was first appointed on 20 May 2026 as Director at Ocim Pharma Private Limited.

The current boards of Shakaribahen Govindbhai Patel's companies include Govindbhai Maganlal Patel (Ocim Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available